Allianz Asset Management GmbH - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,032,252
-79.7%
50,158
-53.6%
0.00%
-77.8%
Q2 2023$5,078,630
+4.2%
108,010
-7.0%
0.01%0.0%
Q1 2023$4,874,620
+40.8%
116,173
+28.0%
0.01%
+28.6%
Q4 2022$3,461,586
+58.0%
90,760
+62.2%
0.01%
+75.0%
Q3 2022$2,191,000
-34.7%
55,948
-26.2%
0.00%
+33.3%
Q3 2021$3,357,000
+54.8%
75,768
+98.5%
0.00%
+50.0%
Q2 2021$2,168,000
-43.1%
38,178
-25.0%
0.00%
-50.0%
Q1 2021$3,810,000
+245.4%
50,908
+299.6%
0.00%
+300.0%
Q4 2020$1,103,000
-45.4%
12,740
-54.5%
0.00%
-50.0%
Q4 2019$2,021,000
-88.5%
27,995
-77.6%
0.00%
-88.2%
Q3 2019$17,578,000
-23.2%
125,019
-0.0%
0.02%
-19.0%
Q2 2019$22,892,000
+27.9%
125,029
+11.1%
0.02%
+16.7%
Q1 2019$17,904,000
+665.1%
112,569
+352.0%
0.02%
+500.0%
Q4 2018$2,340,000
-56.4%
24,904
-34.4%
0.00%
-40.0%
Q3 2018$5,366,000
-9.8%
37,9860.0%0.01%
-16.7%
Q2 2018$5,946,000
-17.0%
37,986
-14.6%
0.01%
-14.3%
Q1 2018$7,163,000
+939.6%
44,474
+962.4%
0.01%
+600.0%
Q4 2017$689,000
+44.4%
4,186
-45.3%
0.00%
Q3 2017$477,000
+30.7%
7,654
+67.2%
0.00%
Q2 2017$365,000
-33.0%
4,578
-40.3%
0.00%
-100.0%
Q1 2017$545,000
-90.7%
7,666
-94.5%
0.00%
-85.7%
Q3 2015$5,846,000
+47.1%
138,145
+153.8%
0.01%
+75.0%
Q2 2015$3,973,00054,4250.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders